National Council for Prescription Drug Programs indexing - billing unit

Manufacturer: National Council for Prescription Drug Programs
Effective date: 2012-07-24
Label type: Indexing - Billing Unit
Version: 1
Source: full-release
Hydrated at: 2026-06-05 02:34:50

Label at a glance#

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
68180-622-10	EA - Each	68180-622	bda2c6f2-b0b0-43ed-b2a3-ecb751e2a46b	1	2012-07-24

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
68180-622	68180-622-10

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	Approval date
A065125-001	CEFTRIAXONE	CEFTRIAXONE SODIUM	EQ 250MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2003-09-30
A065125-002	CEFTRIAXONE	CEFTRIAXONE SODIUM	EQ 500MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2003-09-30
A065125-003	CEFTRIAXONE	CEFTRIAXONE SODIUM	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2003-09-30
A065125-004	CEFTRIAXONE	CEFTRIAXONE SODIUM	EQ 2GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2003-09-30

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 172 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A065125-001	CEFTRIAXONE	EQ 250MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2003-09-30	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A065125-002	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2003-09-30	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A065125-003	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2003-09-30	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A065125-004	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2003-09-30	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A065125-001	CEFTRIAXONE	EQ 250MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2003-09-30	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A065125-002	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2003-09-30	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A065125-003	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2003-09-30	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A065125-004	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2003-09-30	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A065125-001	CEFTRIAXONE	EQ 250MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2003-09-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065125-002	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2003-09-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065125-003	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2003-09-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065125-004	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2003-09-30	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065125-001	CEFTRIAXONE	EQ 250MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2003-09-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065125-002	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2003-09-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065125-003	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2003-09-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065125-004	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2003-09-30	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065125-001	CEFTRIAXONE	EQ 250MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2003-09-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065125-002	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2003-09-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065125-003	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2003-09-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065125-004	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2003-09-30	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065125-001	CEFTRIAXONE	EQ 250MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2003-09-30	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065125-002	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2003-09-30	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065125-003	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2003-09-30	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065125-004	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2003-09-30	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065125-001	CEFTRIAXONE	EQ 250MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2003-09-30	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065125-002	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2003-09-30	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065125-003	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2003-09-30	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065125-004	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2003-09-30	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065125-001	CEFTRIAXONE	EQ 250MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2003-09-30	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065125-002	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2003-09-30	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065125-003	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2003-09-30	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065125-004	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2003-09-30	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065125-001	CEFTRIAXONE	EQ 250MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2003-09-30	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065125-002	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2003-09-30	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065125-003	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2003-09-30	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065125-004	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2003-09-30	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065125-001	CEFTRIAXONE	EQ 250MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2003-09-30	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065125-002	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2003-09-30	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065125-003	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2003-09-30	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065125-004	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2003-09-30	`5bbf6a4d5a75…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 48 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2022-04-08 23:34 UTC	2022-04	A065125-001	AP	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A065125-002	AP	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A065125-003	AP	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A065125-004	AP	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A065125-001	AP	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A065125-002	AP	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A065125-003	AP	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A065125-004	AP	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A065125-001	AP	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A065125-002	AP	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A065125-003	AP	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A065125-004	AP	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A065125-001	AP	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A065125-002	AP	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A065125-003	AP	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A065125-004	AP	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A065125-001	AP	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A065125-002	AP	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A065125-003	AP	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A065125-004	AP	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A065125-001	AP	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A065125-002	AP	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A065125-003	AP	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A065125-004	AP	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A065125-001	AP	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	A065125-002	AP	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	A065125-003	AP	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	A065125-004	AP	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A065125-001	AP	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	A065125-002	AP	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	A065125-003	AP	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	A065125-004	AP	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A065125-001	AP	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	A065125-002	AP	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	A065125-003	AP	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	A065125-004	AP	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A065125-001	AP	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A065125-002	AP	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A065125-003	AP	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A065125-004	AP	1	`3f01610625f2…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.